HomeSitemapContact us

Why we are called Trojantec?

News

Trojantec to present at the 2013 Asco Annual Meeting  [28/05/2013]
AACR Annual Meeting, April 6-10, 2013, Walter E. Convention Center, Washington, DC, USA  [07/04/2013]
RECOMBINANT PROTEIN THERAPEUTICS, CHI's 12th Annual PepTalk, January 21, 2013, Palm Springs Convention Center, Palm Springs, California, USA  [22/01/2013]
ESMO 2012, Vienna, Austria: Friday 28 September - Tuesday 2 October  [08/10/2012]
New treatments against cancer and cancer stem cells  [01/08/2012]
ASCO ANNUAL MEETING June 1-5, 2012, CHICAGO, IL.  [01/06/2012]
AACR ANNUAL MEETING, March 31- April 4, 2012, CHICAGO, IL.  [01/04/2012]
Trojantec raises funds for research and drug development in cancer and cancer stem cell therapeutics  [08/11/2011]
AACR ANNUAL MEETING 2011, ORLANDO, FLORIDA.  [05/04/2011]
Trojantec raises funds for research and drug development in cancer stem cell therapeutics  [11/10/2010]
Trojantec raises funds to advance novel therapeutics  [09/06/2010]
CANCER STEM CELLS CONFERENCE, CAMBRIDGE, MA, USA  [25/03/2010]
European Patent Granted  [24/02/2010]
Presentation by the Company's Chairman  [02/02/2010]
Winners announced in London Technology Fund Competition 2009  [05/11/2009]
ECCO 15 and the 34th ESMO Multidisciplinary Congress, held from the 20th - 24th of September 2009 in Berlin, Germany  [22/09/2009]
Annual Meeting of ASCO held at Orlando, Florida, May 29th - June 2nd, 2009  [29/05/2009]
Annual Conference of AACR held at Denver, Colorado  [22/04/2009]
The 20th International Congress on anti-cancer treatments  [04/02/2009]
San Diego Convention Centre  [16/04/2008]
KEYSTONE SYMPOSIUM  [26/03/2008]
MARIANNA LORDOS CANCER CONFERENCE, 29 FEBRUARY- 2 MARCH 2008  [02/03/2008]
The Role of Cancer Stem Cells in the Initiation and Propagation of Tumorigenesis  [14/02/2008]
The 2nd UK Cancer Stem Cell Meeting  [23/11/2007]
Trojantec Ltd participated at the Antibodies-Europe Conference held in Vienna, Austria 7-8 November 2007  [08/11/2007]
Trojantec Ltd participated at the "The Notch meeting" held in Athens, Greece 23-27 September 2007  [29/09/2007]
Trojantec Announces Data On Notch/numb Signaling Therapeutics To Be Presented At Cancer Stem Cell Conference  [19/04/2007]
Trojantec announces participation in Cancer Conference  [20/12/2006]
Trojantec announces participation in Cancer Stem Cells Conference  [18/12/2006]
Trojantec announces participation in Keynote Symposium  [10/12/2006]
Trojantec is awarded a Research Grant by The Research Promotion Foundation  [05/12/2006]
Trojantec Selects First Lead Candidate for Advanced Preclinical Development  [06/11/2006]
Trojantec to Present at a Cancer Stem Cells Conference in Myconos, Greece  [01/11/2006]
Trojantec along with six other European Groups and Companies is awarded a Research Grant by The European Union  [01/10/2006]
Cancer Research Journal Publishes Data from studies in Notch signaling in human breast cancer  [01/02/2006]
© 2007-2012 Trojantec ltd. All rights reserved.